Administration of lnterleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects

NeuroImmunoModulation

Volumn 4, Issue 5-6, 1997, Pages 258-265

  Avitsur, Ronit ^a   Pollak, Yehuda ^a   Yirmiya, Raz ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Fever; Interleukin 1; Paraventricular nucleus; Rats; Sickness behavior

Indexed keywords

INTERLEUKIN 1;

ADOLESCENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEVER; FOOD INTAKE; ILLNESS BEHAVIOR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FEVER; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; MOTOR ACTIVITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, INBRED F344; RECOMBINANT FUSION PROTEINS; SACCHARIN; THALAMIC NUCLEI; WEIGHT LOSS;

EID: 13144282739     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097345     Document Type: Article

References (45)

1. Kluger MJ: Fever: Role of pyrogens and crvo-gens, Physiol Rev 1991;71:93-127.
2. Besedovsky H, del Rev A: Immuno-ncurocndo-crinc intcraciions: facts and hpyothcscs, En-docr Rev 1996:17:64-102.
3. Dantzcr R, Bluth'c RM, Aubert A, Goodall G, Brcl-Dibal JL, Kent S, Goujon E, Lay'c S, Par-net P, Kelley W: Cytokine actions on behavior; in Rothwcll NJ (ed): Cytokines in the Nervous System, London, Chapman & Hall, 1996. pp 117-144.
4. Yirmiya Y: Behavioral and psychological effects of immune activation: Implications for 'depression due to a general medial condition', CurrOpin Psychiatry 1997;10:470-476.
5. Barbancl G, Ixart G, Szafarczysk A, Malaval F, Asscnmachcr I: Intrahypothalamic infusion of interleukin-Ip increases the release of corticotropin- releasing hormone (CRH 41) and adrc-nocorticotropin hormone (ACTH) in free-moving rats bearing a push-pull cannula in [he median eminence, Brain Res 1990:516:31-36.
6. Saperas E, Yang H, Tachc Y: Interleukin-1 3 acts at hypothalamic sites to inhibit gastric acid secretion in rats, Ant J Physiol 1992:263: G4I4-G4I8.
7. Barbancl G, Gaillet S, Mekaouchc G, Givalois G, Ixart G, Siaud P, Szafarczysk A, Malaval F, Assenmacher I: Complex catecholaminergic modulation of the stimulatory effect of interleukin-Ip on the corticotropic axis, Brain Res 1993;626:31-36.
8. Watanobc H, Takcbc K: Intrahypothalamic perfusion with interleukin-1 beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rat: A comparative perfusion of the paraventricular nucleus and the median eminence, Neurocndo-crinology 1993;57:593-599.
9. Watkins LR, Maicr SF, Goehler LE: Cytokine to brain communication: A review and analysis of alternative mechanisms, Life Sci 1995.57: 1011-1026.
10. Rivcst S, Torres G, Rivicr C: Differential effects of central and peripheral injection of interleukin- I p on brain c-fos expression and neuroendocrine functions, Brain Res 1992:587: 13-23.
11. Brady LS, Lynn AB, Herkcnham M, Gottcsfcld Z: Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain, J Neurosci 1994;14:4951-4964.
12. Ericsson A, Kovacs KJ, Sawchenko PE: A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons, J Neurosci 1994;14:897-913.
13. Vellucci SV, Parrott RF, da Costa AC, Ohkura S, Kendrick KM: Increased body temperature, cortisol secretion and hypothalamic expression of c-fos, corticotropin releasing hormone and interleukin-1P mRNAs, following central administration of interleukin-1 p in the sheep, Mol Brain Res 1995;29:64-70.
14. Day HEW, Akil H: Differential pattern of c-fos mRNA in rat brain following central and systemic administration of intcrlcukin-1 -beta: Implication for mechanism of action, Neuroendocrinology 1996;63:207-218.
15. Dunn AJ: Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone, Life Sci 1988:43:429-435.
16. Komaki G, Arimura A, Koves K: Effect of intravenous injection of IL-ip on PGEj levels in several brain areas as determined by microdialysis, Am J Physiol 1992;262:E246-E251.
17. Mohankumar PS, Quadri SK: Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus, Life Sci 1993;52:1961-1967.
18. Terao A, Oikawa M, Saito M: Cytokine-induced change in hypothalamic norepinephrine turnover: Involvement of corticotropin-releasing hormone and prostaglandins, Brain Res 1993:622:257-261.
19. McCarthy HD, Dryden S, Williams G: Interleukin-1 beta-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y, Am J Physiol 1995;269:E852-E857.
20. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, New York, Academic Press, 1991.
21. Horn T, Wilkinson MF, Landgraf R, Pittman QJ: Reduced febrile responses to pyrogens after lesions of the hypothalamic paraventricular nucleus, Am J Physiol 1994;267:R323-R328.
22. Unger M, Merker G, Roth J, Zeisberger E: Influence of noradrenergic input into the hypothalamic paraventricular nucleus on fever in the guinea pig, Pflügers Arch 1991:419:394- 400.
23. Bock M, Roth J, Kluger MJ, Zeisberger E: Anti-pyresis caused by stimulation of vasopressincr-gic neurons and intrascptal or systemic infu-sionsofy-MSH, Am J Physiol 1994;266:R614-R621.
24. Ruwe WD: Electrical stimulation of the paraventricular nucleus attenuates pyrogen fever in the rabbit, Brain Res 1992;588:181-190.
25. Scammell TE, Elmquist JK, Griffin JD, Saper CB: Ventromedial prcoptic prostaglandin E; activates fever-producing autonomic pathways, J Neurosci 1996;16:6246-6254.
26. Yirmiya R, Avitsur R, Donchin O, Cohen E: Intcrlcukin-1 inhibits sexual behavior in female but not in male rats, Brain Bchav Immun 1995;9:220-233.
27. Yirtniya R: Endotoxin produces a depressive like episode in rais, Brain Res 1996:711:163-174.
28. Yimiiya R, Barak O, Avitsur R, Gallilv R, Wci-denleld J: Intracercbral administralion of Mycoplasma fermemam produces sickness behavior: role of prostaglandins, Brain Res 1997:749: 71-81.
29. Dunn AJ, Antoon M, Chapman Y: Reduction of exploratory behavior by intraperitoneal injection of interleukin I involves brain corticotropin-releasing factor, Brain Res Bull 1991:26: 539-542.
30. Ottemcss IG, Seymour PA, Golden HW, Reynolds JA, Daumy GO: The effects of continuous administration of murine interleukin-lu in the rat, Physiol Bchav 1988:43:797-804.
31. Avitsur R, Donchin O, Cohen E, Yirmiya R: Behavioral effects of interleukin-Ip: modulation by gender, estrus cycle and progesterone, Brain Behav Immun 1995;9:234-241.
32. Hart BL: Biological basis ofthc behavior of sick animals, Neurosci Biobehav Rev 1988:12:123- 137.
33. Walter JS, Meyers P, Krueger JM: Microinjcc-tion of interleukin-1 into brain: Separation of sleep and fever responses, Physiol Behav 1989: 45:169-176.
34. Kent S, Bret-Dibat JI, Kelley KW, Dantzer R: Mechanisms of sickness-induced decreases in food-motivated behavior, Neurosci Biobehav Rev 1996:20:171-175.
35. Kent S, Bluthc RM, Dantzer R, Hardwick AJ, Kelley KW, Rotlnvcll NJ, Vannicc JL: Different receptor mechanisms mediate the pvro-genic and behavioral effects of interleukin-1. Proc Natl Acad Sci USA 1992:89:9117-9120.
36. Linthorst AC, Flachskamm C, Mullcr-Prcuss P, Holsbocr F, Reul JM: Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurolransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study, J Neurosci 1995:15: 2920-2934.
37. Kalsuura G, Gottschall PE, Arimura A: Identification of a high affinity receptor for interleukin-1 beta in rat brain, Biochem Biophys Res Commun 198S: 156:61-67.
38. Wong M, Licinio J: Localization of interleukin 1 type I receptor mRNA in the rat brain, Neu-roimmunmodulation 1994:1:110-115.
39. Ericsson A, Liu C, Hart RP, Sawchenko PE: Type I interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-l-induced cellular activation, J Comp Neurol 1995:361:681-698.
40. Tsagarakis S, Gillies G, Rees LIT, Bcsser GM, Grossman AB: Interleukin-1 directly stimulates the release of corticotropin-releasing factor from rat hypothalamus, Neuroendocrinology 1989:49:98-101.
41. Navarra P, Tsagarakis S, Faria MS, Rees LH, Bcsser GM, Grossman AB: Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway, Endocrinology 1991:128:37-44.
42. Raber J, Pich EM, Koob GF, Bloom FE: IL-I1 potentiates the acetylcholine induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala, Ncurocndocrinolo-gy 1994:59:208-217.
43. Kalra PS, Sahu A, Kalra SA: Interleukin-1 inhibits the ovarian steroid induced luteinizing hormone surge and release of hypothalamic luteinizing hormone releasing hormone in rats, Endocrinology 1990; 126:2145-2152.
44. Yamashita H, Li Z, Inenga K: Effects of inter-leukin-l p on membrane potentials of hypothalamic supraoptic neurons in rats in vitro, Ann NY Acad Sci 1993:689:689-692.
45. Mirtella A, Tringali G, Guerriero G, Ghiara P, Parenla L, Prcziozi P, Navarra P: Evidence that the interleukin-1[i-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors, J Neuroimmunol 1995:171-177.